* Health Catalyst Inc HCAT.OQ reported quarterly adjusted
earnings of 5 cents per share for the quarter ended in March.
The mean expectation of fourteen analysts for the quarter was
for a loss of 4 cents per share.
* Revenue rose 8.5% to $73.87 million from a year ago;
analysts
expected $71.24 million.
* Health Catalyst Inc's reported EPS for the quarter was a
loss
of 60 cents.
* The mean earnings estimate of analysts had fallen by
about 11.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Health Catalyst Inc shares had risen by 4.2% this
quarter and
gained 14.4% so far this year.
* The company reported a quarterly loss of $33.19 million.
* Wall Street's median 12-month price target for Health
Catalyst
Inc is $16.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
9 at 11:11 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.04 0.05 Beat
Dec. 31 2022 -0.11 -0.05 Beat
Sep. 30 2022 -0.19 -0.13 Beat
Jun. 30 2022 -0.10 -0.03 Beat